
    
      Part A: 35 healthy volunteers will be enrolled in a total of 5 cohorts. Each cohort will
      enroll 7 participants with 5 participants randomized to receive NX-13 and 2 participants
      randomized to receive placebo.

      Part B: 21 healthy volunteers will be enrolled in a total of 3 cohorts. Each cohort will
      enroll 7 participants with 5 participants randomized to receive NX-13 and 2 participants
      randomized to receive placebo.
    
  